Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance
Homa Fatma, S. Maurya, Hifzur R. Siddique
Seminars in Cancer Biology (2020) Vol. 83, pp. 166-176
Closed Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability
Yiran Zhu, Bingluo Zhou, Xinyang Hu, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 91
Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Zifei Wang, Wansu Sun, Ruixue Hua, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 60
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 57
Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer
Sravani Pulya, Ambati Himaja, Milan Paul, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12033-12058
Closed Access | Times Cited: 26
Metabolic reprogramming driven by METTL1-mediated tRNA m7G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma
Jie Chen, Qimin Zhou, Shuai Li, et al.
Translational research (2024) Vol. 268, pp. 28-39
Closed Access | Times Cited: 11
Targeting O-GlcNAcylation in cancer therapeutic resistance: The sugar Saga continues
Lulu Chen, Mengxue Hu, Luojun Chen, et al.
Cancer Letters (2024) Vol. 588, pp. 216742-216742
Closed Access | Times Cited: 11
Dual‐Epigenetically Relieving the MYC‐Correlated Immunosuppression via an Advanced Nano‐Radiosensitizer Potentiates Cancer Immuno‐Radiotherapy
Guohao Wang, Jie Yan, Hao Tian, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Open Access | Times Cited: 10
Epigenetics in obesity: Mechanisms and advances in therapies based on natural products
Peng Chen, Yulai Wang, Fuchao Chen, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Ubiquitin-specific proteases: From biological functions to potential therapeutic applications in gastric cancer
Kaiqiang Li, Xiao Bai, Ang-Ting Ke, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116323-116323
Open Access | Times Cited: 8
Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways
Mário Šereš, Katarina Spacayova, Zdena Sulová, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 248-248
Open Access | Times Cited: 1
Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway
Bisheng Cheng, Lingfeng Li, Tianlong Luo, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation
Mojdeh Amini Faskhoudi, Pejman Molaei, Mehrdokht Sadrkhanloo, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153851-153851
Closed Access | Times Cited: 26
Polyploidy and Myc Proto-Oncogenes Promote Stress Adaptation via Epigenetic Plasticity and Gene Regulatory Network Rewiring
Olga V. Anatskaya, Alexander E. Vinogradov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9691-9691
Open Access | Times Cited: 26
Role Of Epigenetic Drugs In Sensitizing Cancers To Anticancer Therapies: Emerging Trends And Clinical Advancements
Deepti Singh, Mohammad Afsar Khan, Hifzur R. Siddique
Epigenomics (2023) Vol. 15, Iss. 8, pp. 517-537
Closed Access | Times Cited: 15
CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma
Zhang Yin, Ranran Yu, Cheng Zhao, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Emerging roles of i-motif in gene expression and disease treatment
Xiaoqing Luo, Jianye Zhang, Yue Gao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
RIT1 Promotes the Proliferation of Gliomas Through the Regulation of the PI3K/AKT/c‐Myc Signalling Pathway
Zhen Liu, Hao‐dong Jiang, Hao‐yuan Kan, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Evaluation of Anticancer Activity of Novel and Tumor-Targeted Glutamine-Conjugated Organotin(IV) Compounds in Colorectal Cancer─An In Vitro and In Vivo Study
Shagun Sharma, Varinder Kaur, Pratibha Duhan, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis
Hong-Fei Yao, Jieqiong Ge, Jiahao Chen, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
RBMS1 promotes the proliferation of glioma cells via regulation of the c-Myc–SSH1 axis
Shen Gu, Weining Wu, Chao Wu, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151586-151586
Closed Access
Trichostatin A augments cell migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma through BRD4/c-Myc endoplasmic reticulum-stress pathway
Yanmin Chen, Wenqian Yang, Yingying Fan, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 11
Closed Access
NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer
Jiali Dai, Xiyi Lu, Chang Zhang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemia
Anran Li, Min Yu, Yue Zhao, et al.
Investigational New Drugs (2025)
Closed Access
Nicotine promotes the progression and metastasis of non-small cell lung cancer by modulating the OTUB1-c-Myc-EZH2 axis
Hua Huang, Chen Ding, Wenhao Zhao, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Page 1 - Next Page

Scroll to top